Resources

6
Dec

PRESS RELEASE – Genoskin launches spatial skin biology platform MANTIS®

PRESS RELEASE - Toulouse, France & Salem, MA, USA - December 6, 2021 GENOSKIN LAUNCHES SPATIAL SKIN BIOLOGY PLATFORM MANTIS® Genoskin launches MANTIS®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS® (Multiplex ANnotated Tissue Imaging System) platform was developed at Infinity (Inserm U1291, France) by a team of experts under the guidance of Dr. Nicolas Gaudenzio, who
Read more
8
Nov

PRESS RELEASE – Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin

Genoskin appoints Dr Nicolas Gaudenzio as Chief Scientific Officer Today, November 8, Genoskin announces the appointment of Dr. Nicolas Gaudenzio as Chief Scientific Officer (CSO), starting in November. Dr. Gaudenzio will lead Genoskin's shift towards new activities Dr. Gaudenzio is a world-renowned researcher and expert in immunology and allergic skin inflammation. He is also principal investigator and leader of a
Read more
28
Oct

De-risking antiaging trials with ex vivo skin models

Article written by Danny Sullivan and first published in Longevity Technology on October 28th, 2021. The original article is available here. Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing With its proprietary ex vivo human skin technologies, French partner research organisation Genoskin says it is paving the way to “better,
Read more
6
Jul

PRESS RELEASE – Genoskin launches the ISR platform®

Genoskin launches the ISR platform®: the first human skin ex vivo platform to study injection site reactions (ISR) ahead of clinical trials Genoskin is evolving and aims to support the biotech and pharmaceutical industries in accelerating their drug development. Today, July 6th 2021, Genoskin announces the launch of the ISR platform®, a new pre-clinical toolbox designed to study injection site
Read more
15
Jun

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals Interested in trying NativeSkin access®? Do you still think that sourcing skin samples directly from hospitals is the only valid way? Let us change your mind with these top advantages to ordering  NativeSkin access® online! NativeSkin access® is a patented human skin model that makes the culture, treatment,
Read more
22
Feb

Using NativeSkin® to study poison ivy-induced dermatitis

Using NativeSkin® to evaluate poison ivy effects  A couple of months ago, Genoskin’s team started to wonder: “Why not try to better understand poison ivy dermatitis through our NativeSkin® model ?” In this article, we summarize information about what is known regarding the poison ivy reaction and what happens on a macroscopic level when poison ivy toxin is applied to
Read more